Major weight loss, pain relief seen with Eli Lilly's next-gen drug in late-stage trial
Eli Lilly's experimental drug, retatrutide, showed strong results in a late-stage trial, helping patients lose nearly 29% of their body weight while reducing osteoarthritis pain.
